查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1712742

2025年药品无菌测试全球市场报告

Pharmaceutical Sterility Testing Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

预计未来几年药品无菌测试的市场规模将快速成长。到 2029 年，这一数字将成长至 31.8 亿美元，年复合成长率（CAGR）为 20.0%。预测期内的成长可归因于生物製药、个人化医疗的成长、外包趋势的增加、对品质保证的重视以及大流行防范措施。预测期内的关键趋势包括快速微生物学方法、配方产品、资料完整性和数数位化、自动化和机器人技术以及先进的分析技术。

药品无菌测试市场的发展归因于药品上市的快速增加和研发（R&D）投资的增加。在药品生产过程中保持无菌状态对于防止污染和确保药品中不存在活微生物至关重要。值得注意的是，2022年3月，英国政府承诺拨款3.47亿美元（2.6亿英镑）支持创新治疗方法和工具的研发倡议，显示其对发展製药业的承诺。此外，IQVIA 于 2021 年 12 月发布的一份报告预测，未来五年新药上市数量将大幅增加，新产品支出也将大幅增加，尤其是在特种药物、利基药物和孤儿药方面。

生技药品销售额的成长预计将显着推动药品无菌测试市场的成长。生物製剂生物来源的生技药品，包括疫苗、血液和血液成分、过敏原、体细胞、基因疗法药物、组织和重组治疗性蛋白质等多种产品。确保这些生技药品的无菌性至关重要，而药品无菌测试提供了必要的品管，以确保这些产品在给患者服用之前没有受到微生物污染。例如，2023 年 11 月，加拿大监管机构专利和药品价格审查委员会报告称，抗癌药物的销售额在 2021 年增长了 10%，2022 年进一步增长了 12%。这些生技药品销售趋势凸显了对无菌测试服务日益增长的需求，以确保这些救命疗法的安全性和有效性。因此，生技药品销售的激增是药品无菌测试市场的主要驱动力，凸显了严格的测试通讯协定在生物製药产业中的关键作用。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场 - 宏观经济情景，包括利率、感染疾病、地缘政治、新冠疫情、经济復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球药品无菌测试市场的 PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素、限制因素）
  • 最终用途产业分析
  • 全球药品无菌测试市场：成长率分析
  • 全球药品无菌测试市场表现：规模与成长，2019-2024
  • 全球药品无菌测试市场预测：规模与成长，2024-2029，2034
  • 全球药品无菌测试总目标市场（TAM）

第六章市场区隔

  • 全球药品无菌测试市场样本、绩效及预测（2019-2024、2024-2029、2034）
  • 无菌药品
  • 医疗设备
  • 生技药品和治疗学
  • 全球药品无菌测试市场（按产品类型、性能和预测）2019-2024 年、2024-2029 年、2034 年
  • 装置
  • 套件和试剂
  • 服务
  • 全球药品无菌测试市场类型、表现及预测（2019-2024、2024-2029、2034）
  • 内部
  • 外包
  • 全球药品无菌测试市场（按测试类型、性能和预测）2019-2024 年、2024-2029 年、2034 年
  • 无菌测试
  • 微生物附着量测试
  • 细菌内毒素检测
  • 全球药品无菌测试市场（依最终用户、绩效及预测）2019-2024、2024-2029、2034
  • 配药药房
  • 医疗设备公司
  • 製药公司
  • 全球药品无菌测试市场：无菌药物细分（按类型、性能和预测），2019-2024 年、2024-2029 年、2034 年
  • 注射药物
  • 点滴解决方案
  • 眼药水
  • 全球药品无菌测试市场：医疗设备细分（按类型、性能和预测），2019-2024 年、2024-2029 年、2034 年
  • 手术器械
  • 植入
  • 导管
  • 全球药品无菌测试市场：生技药品及治疗细分市场（按类型、绩效及预测），2019-2024 年、2024-2029 年、2034 年
  • 疫苗
  • 基因治疗
  • 细胞疗法

第七章 区域和国家分析

  • 全球药品无菌测试市场各地区、绩效及预测（2019-2024、2024-2029、2034）
  • 全球药品无菌测试市场（依国家、地区、绩效及预测）2019-2024、2024-2029、2034

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章 德国市场

第十八章 法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章竞争格局与公司概况

  • 药品无菌测试市场：竞争格局
  • 药品无菌测试市场：公司简介
    • Pacific Biolabs Inc. Overview, Products and Services, Strategy and Financial Analysis
    • STERIS Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Boston Analytical Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Gibraltar Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Sartorius AG Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型创新企业

  • Solvias AG
  • SGS SA
  • Toxikon Inc.
  • Pace Analytical Services LLC
  • Charles River Laboratories International Inc.
  • Nelson Laboratories Inc.
  • Rapid Micro Biosystems Inc.
  • bioMerieux Inc.
  • Merck KGaA
  • WuXi AppTec
  • Sotera Health LLC
  • Dynalabs LLC
  • Infinity Laboratories
  • Eurofins Scientific SE
  • Avomeen Analytical Services

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章 高市场潜力国家、细分市场与策略

  • 2029年药品无菌测试市场：提供新机会的国家
  • 2029年药品无菌测试市场：细分领域带来新机会
  • 2029年药品无菌测试市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手的策略

第36章 附录

简介目录
Product Code: r32953

Pharmaceutical sterility testing is a critical process designed to determine whether biological parenteral products intended for human use contain any extraneous, viable microorganisms. Ensuring the absence of contaminants is crucial for patient safety and the overall quality of medical products. Sterility testing guarantees that the products offered are appropriately free from harmful microorganisms.

Within pharmaceutical sterility testing, two primary types exist: in-house testing and outsourced testing. Various tests, including sterility testing, bioburden testing, and bacterial endotoxin testing, are conducted on sterile drugs, medical devices, biologics, and therapeutics. The bacterial endotoxin test, an in vitro assay, detects bacterial endotoxins by lysing blood cells from horseshoe crabs. Products utilized in this process include instruments, kits, reagents, and services.

The pharmaceutical sterility testing market research report is one of a series of new reports from The Business Research Company that provides pharmaceutical sterility testing market statistics, including pharmaceutical sterility testing industry global market size, regional shares, competitors with a pharmaceutical sterility testing market share, detailed pharmaceutical sterility testing market segments, pharmaceutical sterility testing market trends and opportunities, and any further data you may need to thrive in the pharmaceutical sterility testing industry. This pharmaceutical sterility testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The pharmaceutical sterility testing market size has grown strongly in recent years. It will grow from $1.41 billion in 2024 to $1.54 billion in 2025 at a compound annual growth rate (CAGR) of 9.0%. The growth in the historic period can be attributed to rising demand for quality pharmaceutical products, growing emphasis on drug safety and efficacy, growing demand for biologics and biosimilar drugs, increasing prevalence of infectious diseases, and rising investments in life science research.

The pharmaceutical sterility testing market size is expected to see rapid growth in the next few years. It will grow to $3.18 billion in 2029 at a compound annual growth rate (CAGR) of 20.0%. The growth in the forecast period can be attributed to biopharmaceutical growth, personalized medicine, growing trend of outsourcing, quality assurance emphasis, pandemic preparedness. Major trends in the forecast period include rapid microbiological methods, combination products, data integrity and digitalization, automation and robotics, advanced analytical techniques.

Growth in the pharmaceutical sterility testing market is attributed to an upsurge in drug launches and increased investment in research and development (R&D). Maintaining sterility in drug manufacturing is crucial to prevent contamination and ensure the absence of viable microorganisms in medications. Notably, in March 2022, the UK government pledged a substantial $347 million (£260 million) towards R&D initiatives for innovative treatments and tools, signifying a commitment to advancing the pharmaceutical landscape. Additionally, IQVIA's report from December 2021 projects a significant rise in new drug introductions over the next five years, particularly in specialty, niche, and orphan drugs, accompanied by a substantial increase in spending on new products.

The rise in biologics sales is anticipated to significantly propel the growth of the pharmaceutical sterility testing market. Biologics, which are medicines derived from living organisms, encompass a wide range of products, including vaccines, blood and blood components, allergenics, somatic cells, gene therapies, tissues, and recombinant therapeutic proteins. Ensuring the sterility of these biologics is critical, as pharmaceutical sterility testing provides essential quality control to verify that these products are free from microbial contamination prior to patient administration. For example, in November 2023, the Patented Medicine Prices Review Board, a Canada-based regulatory agency, reported that sales of oncology medicines increased by 10% in 2021 and saw a more significant rise of 12% in 2022. This growing trend in biologics sales underscores the heightened demand for sterility testing services to maintain the safety and efficacy of these life-saving treatments. Consequently, the surge in biologics sales is a key driver for the pharmaceutical sterility testing market, highlighting the critical role of rigorous testing protocols in the biopharmaceutical industry.

Key players in the pharmaceutical sterility testing market are introducing technologically advanced solutions, such as the sterility test isolator workstation (STIW), to address testing challenges and minimize erroneous results. The STIW, a specialized containment system, creates a sterile environment for conducting sterility tests on pharmaceutical products. For example, AUSTAR Group unveiled the Sterility Test Isolator Workstation (STIW) in March 2022 as part of their 'Standards' product range, featuring UDAF and TURB models. This barrier isolator technology significantly reduces false positives, fostering confidence in lab results while lowering operational costs. Designed for secure sterility testing, the STIW ensures protection against contamination, adhering to stringent guidelines. Its integrated bio-decontamination system expedites processing within 30 minutes, optimizing workflow efficiency for operators.

Major companies operating in the pharmaceutical sterility testing market include Pacific Biolabs Inc., STERIS Corporation, Boston Analytical Inc., Gibraltar Laboratories Inc., Sartorius AG, Solvias AG, SGS S.A., Toxikon Inc., Pace Analytical Services LLC, Charles River Laboratories International Inc., Nelson Laboratories Inc., Rapid Micro Biosystems Inc., bioMerieux Inc., Merck KGaA, WuXi AppTec, Sotera Health LLC, Dynalabs LLC, Infinity Laboratories, Eurofins Scientific SE, Avomeen Analytical Services, Microbac Laboratories Inc., Analytical Lab Group LLC, North American Science Associates Inc., Medical Device Testing Services Inc., Microtest Laboratories Inc., BioScreen Testing Services Inc., Microchem Laboratory Inc., Bactolac Pharmaceutical Inc., Micro Quality Labs Inc., Boston Microfluidics Inc., BioPharma Services Inc., Microbiology Research Associates, BioScience Laboratories Inc.

North America was the largest region in the pharmaceutical sterility testing market in 2024. The Middle East is expected to be the fastest-growing region in the global pharmaceutical sterility testing market share during the forecast period. The regions covered in the pharmaceutical sterility testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

The countries covered in the pharmaceutical sterility testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The pharmaceutical sterility testing market includes revenues earned by entities by membrane filtration, direct transfer (product immersion), and product flush. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Pharmaceutical Sterility Testing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on pharmaceutical sterility testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for pharmaceutical sterility testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The pharmaceutical sterility testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Sample: Sterile Drugs; Medical Devices; Biologics and Therapeutics
  • 2) By Product Type: Instruments; Kits and Reagents; Services
  • 3) By Type: In- house; Outsourcing
  • 4) By Test Type: Sterility Testing; Bioburden Testing; Bacterial Endotoxin Testing
  • 5) By End- User: Compounding Pharmacies; Medical Devices Companies; Pharmaceutical Companies
  • Subsegments:
  • 1) By Sterile Drugs: Injectable Drugs; Infusion Solutions; Ophthalmic Solutions
  • 2) By Medical Devices: Surgical Instruments; Implants; Catheters
  • 3) By Biologics And Therapeutics: Vaccines; Gene Therapies; Cell Therapies
  • Companies Mentioned: Pacific Biolabs Inc.; STERIS Corporation; Boston Analytical Inc.; Gibraltar Laboratories Inc.; Sartorius AG
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Pharmaceutical Sterility Testing Market Characteristics

3. Pharmaceutical Sterility Testing Market Trends And Strategies

4. Pharmaceutical Sterility Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Pharmaceutical Sterility Testing Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Pharmaceutical Sterility Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Pharmaceutical Sterility Testing Market Growth Rate Analysis
  • 5.4. Global Pharmaceutical Sterility Testing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Pharmaceutical Sterility Testing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Pharmaceutical Sterility Testing Total Addressable Market (TAM)

6. Pharmaceutical Sterility Testing Market Segmentation

  • 6.1. Global Pharmaceutical Sterility Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Sterile Drugs
  • Medical Devices
  • Biologics and Therapeutics
  • 6.2. Global Pharmaceutical Sterility Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Instruments
  • Kits and Reagents
  • Services
  • 6.3. Global Pharmaceutical Sterility Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • In-house
  • Outsourcing
  • 6.4. Global Pharmaceutical Sterility Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Sterility Testing
  • Bioburden Testing
  • Bacterial Endotoxin Testing
  • 6.5. Global Pharmaceutical Sterility Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Compounding Pharmacies
  • Medical Devices Companies
  • Pharmaceutical Companies
  • 6.6. Global Pharmaceutical Sterility Testing Market, Sub-Segmentation Of Sterile Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Injectable Drugs
  • Infusion Solutions
  • Ophthalmic Solutions
  • 6.7. Global Pharmaceutical Sterility Testing Market, Sub-Segmentation Of Medical Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Surgical Instruments
  • Implants
  • Catheters
  • 6.8. Global Pharmaceutical Sterility Testing Market, Sub-Segmentation Of Biologics And Therapeutics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Vaccines
  • Gene Therapies
  • Cell Therapies

7. Pharmaceutical Sterility Testing Market Regional And Country Analysis

  • 7.1. Global Pharmaceutical Sterility Testing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Pharmaceutical Sterility Testing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Pharmaceutical Sterility Testing Market

  • 8.1. Asia-Pacific Pharmaceutical Sterility Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Pharmaceutical Sterility Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Pharmaceutical Sterility Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Pharmaceutical Sterility Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Pharmaceutical Sterility Testing Market

  • 9.1. China Pharmaceutical Sterility Testing Market Overview
  • 9.2. China Pharmaceutical Sterility Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Pharmaceutical Sterility Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Pharmaceutical Sterility Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Pharmaceutical Sterility Testing Market

  • 10.1. India Pharmaceutical Sterility Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Pharmaceutical Sterility Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Pharmaceutical Sterility Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Pharmaceutical Sterility Testing Market

  • 11.1. Japan Pharmaceutical Sterility Testing Market Overview
  • 11.2. Japan Pharmaceutical Sterility Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Pharmaceutical Sterility Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Pharmaceutical Sterility Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Pharmaceutical Sterility Testing Market

  • 12.1. Australia Pharmaceutical Sterility Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Pharmaceutical Sterility Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Pharmaceutical Sterility Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Pharmaceutical Sterility Testing Market

  • 13.1. Indonesia Pharmaceutical Sterility Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Pharmaceutical Sterility Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Pharmaceutical Sterility Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Pharmaceutical Sterility Testing Market

  • 14.1. South Korea Pharmaceutical Sterility Testing Market Overview
  • 14.2. South Korea Pharmaceutical Sterility Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Pharmaceutical Sterility Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Pharmaceutical Sterility Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Pharmaceutical Sterility Testing Market

  • 15.1. Western Europe Pharmaceutical Sterility Testing Market Overview
  • 15.2. Western Europe Pharmaceutical Sterility Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Pharmaceutical Sterility Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Pharmaceutical Sterility Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Pharmaceutical Sterility Testing Market

  • 16.1. UK Pharmaceutical Sterility Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Pharmaceutical Sterility Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Pharmaceutical Sterility Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Pharmaceutical Sterility Testing Market

  • 17.1. Germany Pharmaceutical Sterility Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Pharmaceutical Sterility Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Pharmaceutical Sterility Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Pharmaceutical Sterility Testing Market

  • 18.1. France Pharmaceutical Sterility Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Pharmaceutical Sterility Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Pharmaceutical Sterility Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Pharmaceutical Sterility Testing Market

  • 19.1. Italy Pharmaceutical Sterility Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Pharmaceutical Sterility Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Pharmaceutical Sterility Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Pharmaceutical Sterility Testing Market

  • 20.1. Spain Pharmaceutical Sterility Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Pharmaceutical Sterility Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Pharmaceutical Sterility Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Pharmaceutical Sterility Testing Market

  • 21.1. Eastern Europe Pharmaceutical Sterility Testing Market Overview
  • 21.2. Eastern Europe Pharmaceutical Sterility Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Pharmaceutical Sterility Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Pharmaceutical Sterility Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Pharmaceutical Sterility Testing Market

  • 22.1. Russia Pharmaceutical Sterility Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Pharmaceutical Sterility Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Pharmaceutical Sterility Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Pharmaceutical Sterility Testing Market

  • 23.1. North America Pharmaceutical Sterility Testing Market Overview
  • 23.2. North America Pharmaceutical Sterility Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Pharmaceutical Sterility Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Pharmaceutical Sterility Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Pharmaceutical Sterility Testing Market

  • 24.1. USA Pharmaceutical Sterility Testing Market Overview
  • 24.2. USA Pharmaceutical Sterility Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Pharmaceutical Sterility Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Pharmaceutical Sterility Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Pharmaceutical Sterility Testing Market

  • 25.1. Canada Pharmaceutical Sterility Testing Market Overview
  • 25.2. Canada Pharmaceutical Sterility Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Pharmaceutical Sterility Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Pharmaceutical Sterility Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Pharmaceutical Sterility Testing Market

  • 26.1. South America Pharmaceutical Sterility Testing Market Overview
  • 26.2. South America Pharmaceutical Sterility Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Pharmaceutical Sterility Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Pharmaceutical Sterility Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Pharmaceutical Sterility Testing Market

  • 27.1. Brazil Pharmaceutical Sterility Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Pharmaceutical Sterility Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Pharmaceutical Sterility Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Pharmaceutical Sterility Testing Market

  • 28.1. Middle East Pharmaceutical Sterility Testing Market Overview
  • 28.2. Middle East Pharmaceutical Sterility Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Pharmaceutical Sterility Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Pharmaceutical Sterility Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Pharmaceutical Sterility Testing Market

  • 29.1. Africa Pharmaceutical Sterility Testing Market Overview
  • 29.2. Africa Pharmaceutical Sterility Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Pharmaceutical Sterility Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Pharmaceutical Sterility Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Pharmaceutical Sterility Testing Market Competitive Landscape And Company Profiles

  • 30.1. Pharmaceutical Sterility Testing Market Competitive Landscape
  • 30.2. Pharmaceutical Sterility Testing Market Company Profiles
    • 30.2.1. Pacific Biolabs Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. STERIS Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Boston Analytical Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Gibraltar Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Sartorius AG Overview, Products and Services, Strategy and Financial Analysis

31. Pharmaceutical Sterility Testing Market Other Major And Innovative Companies

  • 31.1. Solvias AG
  • 31.2. SGS S.A.
  • 31.3. Toxikon Inc.
  • 31.4. Pace Analytical Services LLC
  • 31.5. Charles River Laboratories International Inc.
  • 31.6. Nelson Laboratories Inc.
  • 31.7. Rapid Micro Biosystems Inc.
  • 31.8. bioMerieux Inc.
  • 31.9. Merck KGaA
  • 31.10. WuXi AppTec
  • 31.11. Sotera Health LLC
  • 31.12. Dynalabs LLC
  • 31.13. Infinity Laboratories
  • 31.14. Eurofins Scientific SE
  • 31.15. Avomeen Analytical Services

32. Global Pharmaceutical Sterility Testing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Pharmaceutical Sterility Testing Market

34. Recent Developments In The Pharmaceutical Sterility Testing Market

35. Pharmaceutical Sterility Testing Market High Potential Countries, Segments and Strategies

  • 35.1 Pharmaceutical Sterility Testing Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Pharmaceutical Sterility Testing Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Pharmaceutical Sterility Testing Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer